Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$98.56 - $119.91 $461,260 - $561,178
-4,680 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$91.91 - $110.37 $157,349 - $188,953
1,712 Added 57.68%
4,680 $513,000
Q2 2021

Aug 13, 2021

BUY
$86.24 - $95.92 $255,960 - $284,690
2,968 New
2,968 $278,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Gqg Partners LLC Portfolio

Follow Gqg Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gqg Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gqg Partners LLC with notifications on news.